Jabra Enhance Select M3 vs Resound Vivia 9 60S microRIE

The Jabra Enhance Select M3 is a premium OTC hearing aid priced at $1,995, earning an A grade with a SoundScore of 4.1/5 in our lab testing. This behind-the-ear device delivers strong overall performance, positioning it well above the OTC category average of 3.69/5. In our testing, the Enhance Select M3 demonstrated notable strengths in speech clarity for quiet environments, scoring 3.8/5—a solid result that sits 0.95 points above the category average. Feedback handling proved excellent at 4.6/5, essentially matching the already-high category standard. Music streaming performance also exceeded category norms by 0.87 points, though the absolute score of 2.8/5 remains mixed rather than exceptional. The device shows limitations in challenging listening situations. Speech in noise scored 1.3/5, falling 0.18 points below the category average and representing a low absolute performance level. Own-voice comfort scored 2.7/5—above the category average by 0.18 points but only mixed in absolute terms, which may affect naturalness during conversations. Consumers seeking alternatives may find similar or better sound performance at lower price points from devices like the Sennheiser All Day Clear or Jabra Enhance Pro 20 at Costco. The Enhance Select M3 is best suited for those who prioritize speech clarity in quieter settings and reliable feedback control, but who encounter fewer noisy environments in their daily routines.

The ReSound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In our lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 39 prescription hearing aids tested. This device shows a mixed performance profile. Its standout strength is own-voice comfort, scoring 3.4/5—a solid result that sits 0.70 points above the category average. Speech clarity in quiet environments also performs at category average with a score of 3.4/5. Feedback handling is strong in absolute terms at 4.2/5, though this falls 0.52 points below the category average, reflecting the high bar set by competing prescription devices. The Vivia 9's most notable weakness is speech understanding in noisy environments, where it scored just 1.1/5—a low result that trails the category average by 0.96 points. Music streaming performance is mixed at 2.6/5, sitting slightly below average. These limitations are worth considering given the premium price positioning. For listeners who prioritize comfortable own-voice perception and primarily encounter quieter listening situations, the Vivia 9 may be suitable. However, those frequently in challenging noise environments should note that several alternatives in this price range—including the Phonak Sphere Infinio and Oticon Intent—deliver stronger overall performance in our testing. Budget-conscious shoppers may also find comparable sound quality at lower price points with options like the Jabra Enhance Pro 20 at Costco.